Literature DB >> 316435

Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor.

M Gouault-Heilmann, M D Dumont, L Intrator, C Chenal, J L Lejonc.   

Abstract

This report describes a patient without evident underlying disease, in whom an acquired von Willebrand's syndrome was discovered before surgery. Coagulation abnormalities included a borderline bleeding time, a low retention of platelets on glass beads, decreased levels of factor VIII procoagulant activity (VIIIAHF), factor VIII-related antigen (VIIIAg), and ristocetin-induced agglutination cofactor (VIIIVWF). After cryoprecipitate infusion the patient did not have the expected rise and there was no secondary increment in VIIIAHF. The patient was treated with prednisone for three weeks without significant improvement in the laboratory findings. Spontaneous resolution was observed long after this therapy. The haemostatic abnormalities were attributable to the presence of an inhibitor directed against VIIIVWF. The inhibitor was found in the IgM fraction. Its autoimmune nature is probable although we failed to demonstrate any inhibitory effect of Fab obtained from the patient's purified IgM. Despite the lack of inhibitory effect against VIIIAHF and VIIIAg, the low levels of all three activities of the factor VIII complex could be explained by the short half-life of immune complexes between factor VIII and the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316435      PMCID: PMC1145886          DOI: 10.1136/jcp.32.10.1030

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Acquired von Willebrand syndrome with inhibitors both to factor VIII clotting activity and ristocetin-induced platelet aggregation.

Authors:  P Stableforth; G L Tamagnini; K M Dormandy
Journal:  Br J Haematol       Date:  1976-08       Impact factor: 6.998

2.  Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.

Authors:  A Moore; G D Ross; R L Nachman
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

3.  Platelet function and immunologic parameters in von Willebrand's disease following cryoprecipitate and factor VIII concentrate infusion.

Authors:  J R Chediak; M C Telfer; D Green
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965

4.  Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.

Authors:  C Gazengel; A M Prieur; C Jacques; D Buriot; J Nedellec; F Josso
Journal:  Am J Hematol       Date:  1978       Impact factor: 10.047

5.  Low factor-VIII-like antigen in acquired Von Willebrand's syndrome and response to treatment.

Authors:  G I Ingram; C R Prentice; C D Forbes; J Leslie
Journal:  Br J Haematol       Date:  1973-07       Impact factor: 6.998

6.  Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy.

Authors:  M J Mant; J Hirsh; J Gauldie; J Bienenstock; G F Pineo; K H Luke
Journal:  Blood       Date:  1973-09       Impact factor: 22.113

7.  Production site of bleeding factor. (Acquired morbus von Willebrand).

Authors:  J J Veltkamp; P Stevens; M von der Plas; E A Loeliger
Journal:  Thromb Diath Haemorrh       Date:  1970-05-31

8.  Acquired von Willebrand's disease, platelet-release defect and angiodysplasia.

Authors:  T K Rosborough; W R Swaim
Journal:  Am J Med       Date:  1978-07       Impact factor: 4.965

9.  Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.

Authors:  J H Joist; J F Cowan; T S Zimmerman
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

10.  Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.

Authors:  H J Weiss; L W Hoyer; F R Rickles; A Varma; J Rogers
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  2 in total

1.  Acquired von Willebrand disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisone.

Authors:  A K Stewart; M F Glynn
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 2.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.